These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16594481)

  • 1. [Diaschisis phenomenon in different neurological diseases].
    Paradowski B; Pawlik B
    Wiad Lek; 2005; 58(11-12):675-7. PubMed ID: 16594481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The phenomenon of diaschisis in cerebral vascular disease].
    González-Aguado E; Martí-Fábregas J; Martí-Vilalta JL
    Rev Neurol; 2000 May 16-31; 30(10):941-5. PubMed ID: 10919192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shock, diaschisis and von Monakow.
    Engelhardt E; Gomes Mda M
    Arq Neuropsiquiatr; 2013 Jul; 71(7):487-9. PubMed ID: 23857617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Monakow concept of diaschisis: origins and perspectives.
    Finger S; Koehler PJ; Jagella C
    Arch Neurol; 2004 Feb; 61(2):283-8. PubMed ID: 14967781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemispherectomy and diaschisis: rapid improvement in cerebral functions after right hemispherectomy in a six year old child.
    Smith A; Walker ML; Myers G
    Arch Clin Neuropsychol; 1988; 3(1):1-8. PubMed ID: 14589560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in neurology.
    Ojini FI
    Niger Postgrad Med J; 2007 Jun; 14(2):146-50. PubMed ID: 17599115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current cell therapy strategies for repairing the central nervous system].
    Féron F
    Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S23-30. PubMed ID: 18087226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuclear medicine imaging in neurology and psychiatry].
    Gratz S
    Dtsch Med Wochenschr; 2008 May; 133 Suppl 1():S3. PubMed ID: 18437638
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature].
    Lagodka A; Robert P
    Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
    Nanou A; Azzouz M
    Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive substrates and their treatments in neurodegenerative diseases.
    Lauterbach EC
    Neurol India; 2006 Sep; 54(3):246-7. PubMed ID: 16936377
    [No Abstract]   [Full Text] [Related]  

  • 12. A network dysfunction perspective on neurodegenerative diseases.
    Palop JJ; Chin J; Mucke L
    Nature; 2006 Oct; 443(7113):768-73. PubMed ID: 17051202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene transfer therapy for neurodegenerative disorders.
    Feigin A; Eidelberg D
    Mov Disord; 2007 Jul; 22(9):1223-8; quiz 1369. PubMed ID: 17393533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of conformation-specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases.
    Leliveld SR; Korth C
    J Neurosci Res; 2007 Aug; 85(11):2285-97. PubMed ID: 17497676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging: an important factor for the pathogenesis of neurodegenerative diseases.
    Farooqui T; Farooqui AA
    Mech Ageing Dev; 2009 Apr; 130(4):203-15. PubMed ID: 19071157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases.
    Hickey MG; Demaerschalk BM; Caselli RJ; Parish JM; Wingerchuk DM
    Neurologist; 2007 Mar; 13(2):98-101. PubMed ID: 17351532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurodegenerative diseases and tea].
    Barranco-Quintana JL; Allam MF; Del Castillo AS; Navajas RF
    Rev Neurol; 2007 Mar 16-31; 44(6):381-2. PubMed ID: 17385176
    [No Abstract]   [Full Text] [Related]  

  • 18. [CSF biomarkers: proteomics investigations and clinical applications in neurodegenerative disorders].
    Gabelle A; Roche S; Lehmann S
    Rev Neurol (Paris); 2009 Mar; 165(3):213-22. PubMed ID: 18808768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin/thrombin and the thrombin receptors PAR-1 and PAR-4 in the brain: localization, expression and participation in neurodegenerative diseases.
    Sokolova E; Reiser G
    Thromb Haemost; 2008 Oct; 100(4):576-81. PubMed ID: 18841278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From care to cure.
    Riederer BM; Leuba G
    Brain Res Bull; 2009 Oct; 80(4-5):171-2. PubMed ID: 19683033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.